Cosmo Pharmaceuticals NV
OTC:CMOPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
OTC:CMOPF
|
IE |
|
First Reliance Bancshares Inc
OTC:FSRL
|
US |
|
P
|
Prosperity Investment Holdings Ltd
HKEX:310
|
HK |
|
Portmeirion Group PLC
LSE:PMP
|
UK |
|
R8 Capital Investments PLC
LSE:MODE
|
UK |
|
N
|
Network18 Media & Investments Ltd
BSE:532798
|
IN |
|
Lu-Ve SpA
MIL:LUVE
|
IT |
|
S
|
S Foods Inc
TSE:2292
|
JP |
|
B
|
BCI Minerals Ltd
F:BC3
|
AU |
|
Seplat Energy PLC
OTC:SEPLF
|
NG |
|
Proto Labs Inc
NYSE:PRLB
|
US |
|
S
|
Shandong Weigao Group Medical Polymer Co Ltd
OTC:SHWGY
|
CN |
Bankruptcy Probability
Cosmo Pharmaceuticals NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cosmo Pharmaceuticals NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IE |
|
Cosmo Pharmaceuticals NV
SIX:CMHC
|
812.8m CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cosmo Pharmaceuticals NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cosmo Pharmaceuticals NV has total debt of 3.6m EUR. This includes both short-term (0 EUR) and long-term (3.6m EUR) debt.
You can find a full breakdown on its Balance Sheet.